why choose us

First received: June 05, 2023

Clinical Trial: Gepant treAtments: EffectIveNess and tolERability (GAINER)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Migraine

Study Type: OBSERVATIONAL


Official Title: Effectiveness and Tolerability of Rimegepant as Acute Migraine Treatment: a Prospective, Multicentric, Cohort Study (GAINER)

Brief Summary: The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as acute migraine treatment in a cohort of episodic or chronic migraine patients.

Read more